These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27733560)
1. Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson's disease. Lipp MM; Batycky R; Moore J; Leinonen M; Freed MI Sci Transl Med; 2016 Oct; 8(360):360ra136. PubMed ID: 27733560 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease. Safirstein BE; Ellenbogen A; Zhao P; Henney HR; Kegler-Ebo DM; Oh C Clin Ther; 2020 Jun; 42(6):1034-1046. PubMed ID: 32482490 [TBL] [Abstract][Full Text] [Related]
3. Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease. Hauser RA; Isaacson SH; Ellenbogen A; Safirstein BE; Truong DD; Komjathy SF; Kegler-Ebo DM; Zhao P; Oh C Parkinsonism Relat Disord; 2019 Jul; 64():175-180. PubMed ID: 30992235 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. LeWitt PA; Hauser RA; Pahwa R; Isaacson SH; Fernandez HH; Lew M; Saint-Hilaire M; Pourcher E; Lopez-Manzanares L; Waters C; Rudzínska M; Sedkov A; Batycky R; Oh C; Lancet Neurol; 2019 Feb; 18(2):145-154. PubMed ID: 30663606 [TBL] [Abstract][Full Text] [Related]
5. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson's disease. Stocchi F; Vacca L; Stirpe P; Torti M Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1189-1195. PubMed ID: 30479171 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease. LeWitt PA; Pahwa R; Sedkov A; Corbin A; Batycky R; Murck H J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):155-161. PubMed ID: 29161531 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease. LeWitt PA; Hauser RA; Grosset DG; Stocchi F; Saint-Hilaire MH; Ellenbogen A; Leinonen M; Hampson NB; DeFeo-Fraulini T; Freed MI; Kieburtz KD Mov Disord; 2016 Sep; 31(9):1356-65. PubMed ID: 27090868 [TBL] [Abstract][Full Text] [Related]
15. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study. Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069 [TBL] [Abstract][Full Text] [Related]
17. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa. Metman LV; Hoff J; Mouradian MM; Chase TN Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial. Waters CH; Nausieda P; Dzyak L; Spiegel J; Rudzinska M; Silver DE; Tsurkalenko ES; Kell S; Hsu A; Khanna S; Gupta S CNS Drugs; 2015 Apr; 29(4):341-50. PubMed ID: 25895021 [TBL] [Abstract][Full Text] [Related]
19. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety. Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940 [TBL] [Abstract][Full Text] [Related]
20. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment. Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]